Christine Klein
Cited by
Cited by
Phenomenology and classification of dystonia: a consensus update
A Albanese, K Bhatia, SB Bressman, MR DeLong, S Fahn, VSC Fung, ...
Movement disorders 28 (7), 863-873, 2013
Genome-wide association study reveals genetic risk underlying Parkinson's disease
J Simon-Sanchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, ...
Nature genetics 41 (12), 1308-1312, 2009
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ...
Nature genetics 46 (9), 989-993, 2014
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ...
The Lancet Neurology 7 (7), 583-590, 2008
Parkinson's disease
BR Bloem, MS Okun, C Klein
The Lancet 397 (10291), 2284-2303, 2021
Genetics of Parkinson’s disease
C Klein, A Westenberger
Cold Spring Harbor perspectives in medicine 2 (1), a008888, 2012
Parkin and PINK1 mitigate STING-induced inflammation
DA Sliter, J Martinez, L Hao, XI Chen, N Sun, TD Fischer, JL Burman, Y Li, ...
Nature 561 (7722), 258-262, 2018
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ...
Movement disorders 32 (9), 1264-1310, 2017
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius, G Senthil, R Saunders-Pullman, E Ohmann, A Deligtisch, ...
New England Journal of Medicine 354 (4), 424-425, 2006
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database
CM Lill, JT Roehr, MB McQueen, FK Kavvoura, S Bagade, BMM Schjeide, ...
PLoS genetics 8 (3), e1002548, 2012
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease
O Cooper, H Seo, S Andrabi, C Guardia-Laguarta, J Graziotto, ...
Science translational medicine 4 (141), 141ra90-141ra90, 2012
Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells
P Seibler, J Graziotto, H Jeong, F Simunovic, C Klein, D Krainc
Journal of Neuroscience 31 (16), 5970-5976, 2011
A major lung cancer susceptibility locus maps to chromosome 6q23–25
JE Bailey-Wilson, CI Amos, SM Pinney, GM Petersen, M De Andrade, ...
The American Journal of Human Genetics 75 (3), 460-474, 2004
The DYT1 phenotype and guidelines for diagnostic testing
SB Bressman, C Sabatti, D Raymond, D De Leon, C Klein, PL Kramer, ...
Neurology 54 (9), 1746-1753, 2000
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
V Bonifati, CF Rohe, GJ Breedveld, E Fabrizio, M De Mari, C Tassorelli, ...
Neurology 65 (1), 87-95, 2005
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration
B Dehay, A Ramirez, M Martinez-Vicente, C Perier, MH Canron, ...
Proceedings of the National Academy of Sciences 109 (24), 9611-9616, 2012
PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling
VA Morais, D Haddad, K Craessaerts, PJ De Bock, J Swerts, S Vilain, ...
Science 344 (6180), 203-207, 2014
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
C Klein, K Lohmann-Hedrich, E Rogaeva, MG Schlossmacher, AE Lang
The Lancet Neurology 6 (7), 652-662, 2007
Lysosomal impairment in Parkinson's disease
B Dehay, M Martinez‐Vicente, GA Caldwell, KA Caldwell, Z Yue, ...
Movement Disorders 28 (6), 725-732, 2013
LRRK2 in Parkinson disease: challenges of clinical trials
E Tolosa, M Vila, C Klein, O Rascol
Nature Reviews Neurology 16 (2), 97-107, 2020
The system can't perform the operation now. Try again later.
Articles 1–20